ThinkstockPalo Alto Networks, Inc. (NYSE: PANW) reported its fiscal fourth quarter financial results after the markets closed on Wednesday. The company had $0.28 in earnings per share (EPS) on $283.9 million in revenue compared…
Lululemon Athletica is scheduled to report its fiscal second-quarter financial results before the markets open on Thursday.
Despite the current market volatility, Merrill Lynch believes that Goldman Sachs can weather this storm and come out ahead in the long run.
A new Oppenheimer report details where the firm thinks alternative energy companies are and what direction they stand to go.
Akebia Therapeutics has had a rough time this year, but shares took a sharp left turn in Wednesday's session on news of positive study results.
Penumbra Inc. has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
When investors see a drop of almost 80% in a share price, the question of long-term viability is almost impossible to ignore.
At Home Group Inc. has with the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Palo Alto Networks is scheduled to report its fiscal fourth-quarter financial results after the markets close on Wednesday.
24/7 Wall St. has put together a preview of Kroger, Lululemon and some of the major companies reporting their quarterly results this week.
Over the past week, a few biotech companies made absolutely massive runs. Here is information about some of them, as well as recent trading activity and the consensus price target.
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and added some color.
Markets were sliding into the close on Friday, and they were dragged down in part to major auto companies.
Traders expected increased volatility in this session, being that this is the Friday before a holiday weekend.
PointClickCare has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
On Medtronic, Oppenheimer has an Outperform rating and a $86 price target, implying upside of 25% from current prices.
Twitter’s management believes it has reached early adopters and technology enthusiasts, but has not cracked the mass market yet.
Friday's top analyst upgrades, downgrades and initiations include BP, Caterpillar, Ciena, CME and Campbell Soup.
CEO Elon Musk announced in a tweet that Tesla will begin delivering its new Model X Signature series late this month.
Lannett climbed high on Thursday after announcing the signing of a definitive agreement to purchase UCB's generics unit, Kremers Urban, for $1.23 billion.